Phase II study of KRN8602, 3′-deamino-3′-morpholino- 13-deoxo-10-hydroxycarminomycin hydrochloride, MX2 · HCl in patients with metastatic breast cancer Noriyuki KatsumataToru WatanabeOsahiko Abe ORIGINAL ARTICLE Pages: 441 - 444
Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats Merrill J. EgorinZhi-Min YuanJulie L. Eiseman ORIGINAL ARTICLE Pages: 445 - 453
Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors William C. ZamboniLaura C. BowmanClinton F. Stewart ORIGINAL ARTICLE Pages: 454 - 460
Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patients Francesco BoccardoAlessandra RubagottiPaola Marroni ORIGINAL ARTICLE Pages: 461 - 466
A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer Kiyoshi MoriSuguru MachidaKeigo Tominaga ORIGINAL ARTICLE Pages: 467 - 470
Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience Nuhad K. IbrahimGabriel N. HortobagyiAman U. Buzdar ORIGINAL ARTICLE Pages: 471 - 478
Thirteen-week oral toxicity study of difluoromethylornithine in combination with tamoxifen citrate in female dogs Alan P. BrownRobert L. MorrisseyBarry S. Levine ORIGINAL ARTICLE Pages: 479 - 488
Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors Robert T. KodaAgustin A. GarciaFranco M. Muggia ORIGINAL ARTICLE Pages: 489 - 496
A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer Smitha SubramanyanMartin D. AbeloffM. John Kennedy ORIGINAL ARTICLE Pages: 497 - 502
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy Guy CantinBernard L'EspéranceMartin Gyger ORIGINAL ARTICLE Pages: 503 - 506
Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification Gregory P. KalemkerianXiaolan OuGeorge R. Pettit ORIGINAL ARTICLE Pages: 507 - 515
Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma – drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study Vinodh R. Nannan PandayRichard M. W. HoetelmansJos H. Beijnen SHORT COMMUNICATION Pages: 516 - 519
Possible excretion of etoposide via the intestinal mucosa Nathalie PerdaemsNathalie CaunesEtienne Chatelut LETTER TO THE EDITORS Pages: 520 - 521
